Gemigliptin attenuates reducing sugar-induced oxidative damage in MC3T3-E1 osteoblasts and improves osteoblastic differentiation
Life Cycle · 2023
DOI: 10.54724/lc.2023.11 ↗Kurz gefasst
Fachartikel in der Zeitschrift Life Cycle, 2023. Verfasst von Hyunji Sang und 5 weiteren Autor:innen. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: LG Life Sciences, Inc, South Korea.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Förderung
- LG Life Sciences, Inc, South Korea
Zitieren
APA
Sang, H., Kim, J., Cho, S. K., Suh, K. S., Jung, W., & Rhee, S. Y. (2023). Gemigliptin attenuates reducing sugar-induced oxidative damage in MC3T3-E1 osteoblasts and improves osteoblastic differentiation. Life Cycle. https://doi.org/10.54724/lc.2023.11
Vancouver
Sang H, Kim J, Cho SK, Suh KS, Jung W, Rhee SY. Gemigliptin attenuates reducing sugar-induced oxidative damage in MC3T3-E1 osteoblasts and improves osteoblastic differentiation. Life Cycle. 2023. doi:10.54724/lc.2023.11
BibTeX
@article{Sang2023,
author = {Sang, Hyunji and Kim, Jaewon and Cho, Sung Kweon and Suh, Kwang Sik and Jung, Woon-Won and Rhee, Sang Youl},
title = {Gemigliptin attenuates reducing sugar-induced oxidative damage in MC3T3-E1 osteoblasts and improves osteoblastic differentiation},
journal = {Life Cycle},
year = {2023},
doi = {10.54724/lc.2023.11}
}
EUVIMED